Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a study of pembrolizumab and carboplatin in patients with metastatic breast cancer, including study details, participation criteria, and outcome measures. It also shows the study’s completed status and posted results information.
    Difference
    57%
    Check dated 2026-11-09T14:50:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:29:45.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH terminology changes related to the transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T15:44:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision updates from v3.7.1 to v3.7.2, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:46:56.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-13T04:09:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating that access to the study record is blocked.
    Difference
    20%
    Check dated 2026-09-21T22:37:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.